CALCIFYING DISEASES HAVE NOW A NOVEL BIOMARKER
based on Inorganic
Pyrophosphate (PPi) quantification
Discover cutting-edge solutions for understanding calcification diseases with aiPyx. Our dedicated team of experts offers a range of services, including reliably measuring calcification concentration in vascular network. Benefit from our UNIQUE patented Inorganic Pyrophosphate (PPi) dosage, targeting rare diseases including PXE (Pseudoxanthoma Elasticum), GACI (Generalized Arterial Calcification of Infancy), ACDC (Arterial calcification due to deficiency of CD73) and gain invaluable insights to address key pathologies. Contact us today for more information and start your journey towards effective calcification better understanding.
Understanding Body Calcification and Innovative Diagnostic Solutions | aiPyx
At aiPyx, we specialize in the understanding and diagnostic of body calcification. With our extensive knowledge of different types of calcification and advanced diagnostic techniques. Our pioneering inorganic pyrophosphate dosage, backed by patented technologies, specifically targets key calcifying pathologies and uncommon disorders like PXE, GACI and ACDC. Discover the innovative approaches we offer for understanding body calcification by contacting our expert team today.
Innovative Solutions for Calcification and Key Pathologies
At aiPyx, we are committed to providing innovative solutions to provide accurate calcification dosages for key calcifying pathologies such as Diabetes. We offer pioneering inorganic pyrophosphate dosage, a patent-based dosage solution, and quantify Inorganic Pyrophosphate (PPi) relaibly to accelerate chronic and rare calcifying diseases diagnostic and follow-up.
Pioneering Inorganic Pyrophosphate Dosage: Revolutionizing Calcification Diagnostics
At aiPyx, we are leading the way in inorganic pyrophosphate dosage. Founded in 2024 with a CNRS patent, we are bringing to Patients, Healthcare Professonnnals and Researchers a novel biomarker to reliably measure Inorganic Pyrophosphate in body fluids.
Our pioneering dosage is addressing key pathologies in nephrology, rheumatology and cardiology, and it has been proven to be effective in adressing rare diseases like PXE. We are proud to be the first to develop a dosage solution that is based on a patented process, and we are committed to continuing to develop our technology to better serve patients.
Discover Our Solutions
- Pioneering Inorganic Pyrophosphate Dosage to address key calcifying pathologies.
- Patented dosage solution to measure body fluid calcification concentrations.
- Expert team of professionals to provide accurate dosages and UNIQUE artificial-intelligence based calcification scores using medical images
Patients
Professionals
Technology
Unmet needs
The Board
aiPyx – Pioneering Inorganic Pyrophosphate Dosage Solutions
Welcome to aiPyx, a biotechnological company dedicated to providing cutting-edge solutions to address a wide range of medical challenges. We are pioneers in the field of inorganic pyrophosphate dosage, with our patented dosage solution designed to accurately assess calcification in the human body. Our experienced team is committed to providing our customers with leading technology and reliable solutions. Get in touch with us today for more information or to discuss your needs.
Contact info
Address:
aiPyx,
Business Pole IPCA 407 – Allée Pierre Ziller
1047 route des Dolines – Sophia-Antipolis
06560 VALBONNE, France
Phone: +33 (0) 6 88 28 44 32
Email: aip.ga@aipyxdx.com
Contact us now for cutting-edge calcification solutions and start your journey to better health today!
Address
aiPyx
Business Pole IPCA 407
Allée Pierre Ziller
1047 route des Dolines
Sophia-Antipolis
06560 VALBONNE, France
Contact
Phone: +33 (0) 6 88 28 44 32
Email: aip.ga@aipyxdx.com
More links
© 2024 aiPyx